BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15305407)

  • 1. Validation of the Composite Laryngeal Recurrence Staging System.
    Lacy PD; Kennedy JT; Piccirillo JF
    Cancer; 2004 Aug; 101(4):761-7. PubMed ID: 15305407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification.
    León X; López M; García J; Viza I; Gich I; Quer M
    Head Neck; 2008 Jul; 30(7):939-45. PubMed ID: 18302258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a new staging system for patients with recurrent laryngeal squamous cell carcinoma.
    Lacy PD; Piccirillo JF
    Cancer; 1998 Sep; 83(5):910-7. PubMed ID: 9731894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
    Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
    Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China.
    Ji W; Guan C; Pan Z
    Acta Otolaryngol; 2008 May; 128(5):574-7. PubMed ID: 18421614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of local failure in early laryngeal cancer.
    Lohynska R; Slavicek A; Bahanan A; Novakova P
    Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival rates of sinonasal squamous cell carcinoma with the new AJCC staging system.
    Lee CH; Hur DG; Roh HJ; Rha KS; Jin HR; Rhee CS; Min YG
    Arch Otolaryngol Head Neck Surg; 2007 Feb; 133(2):131-4. PubMed ID: 17309980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
    Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
    Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage treatment for recurrent oral squamous cell carcinoma.
    Sun GW; Tang EY; Yang XD; Hu QG
    J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The impact of extracapsular spread and desmoplasia on local recurrence in patients with malignant tumors of the larynx and hypopharynx].
    de Diego Sastre JI; Prim Espada MP; Hardisson Hernáez D; Gavilán Bouzas J
    Acta Otorrinolaringol Esp; 1999; 50(6):459-62. PubMed ID: 10502698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage grouping reliability: TNM '97 versus TANIS in laryngeal cancer.
    Carinci F; Farina A; Pelucchi S; Pastore A; Longhini L; Urso RG; Calearo C
    Otolaryngol Head Neck Surg; 1999 Apr; 120(4):499-501. PubMed ID: 10187941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
    Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
    Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
    Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
    Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of the larynx: the northern Alberta experience.
    Marck PA; Lupin AJ
    J Otolaryngol; 1989 Dec; 18(7):344-9. PubMed ID: 2593218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.